T. Taylor

发表

NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD

S. Steinberg, A. Berger, S. Mitchell, 2014, Bone Marrow Transplantation.

Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures

S. Steinberg, K. Baird, S. Mitchell, 2014, Bone Marrow Transplantation.

Oral Chronic Graft-vs.-Host Disease Characterization Using the NIH Scale

S. Steinberg, K. Baird, S. Mitchell, 2012, Journal of dental research.

National Institutes of Health (NIH) Chronic GVHD Staging in Severely Affected Patients: Organ and Global Scoring Correlate with Established Indicators of Disease Severity and Prognosis

J. Shelhamer, J. Gea-Banacloche, K. Baird, 2013 .

Sickle related events following cardiac catheterisation: risk implication for other invasive procedures

R. Lederman, G. Kato, C. Minniti, 2018, British journal of haematology.

At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT.

J. Tisdale, M. Hsieh, W. Coles, 2017, Blood.

Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixafor.

Thomas E. Hughes, S. Tsai, D. Stroncek, 2020, Haematologica.

Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixafor

Thomas E. Hughes, S. Tsai, M. Weiss, 2019, Haematologica.

Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease.

Thomas E. Hughes, S. Tsai, M. Weiss, 2021, Blood advances.

NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT

J. Shelhamer, S. Steinberg, S. Gadalla, 2014, Bone Marrow Transplantation.

Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT.

J. Powell, J. Tisdale, M. Hsieh, 2017, Blood advances.

Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity

S. Steinberg, M. Bishop, K. Baird, 2011, Leukemia.

Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease Patients.

S. Steinberg, A. Im, K. Baird, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.